Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

NCT00239733 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Stopped failure to enroll additional subjects

Conditions

Thrombocytopenia
Hepatitis C
HIV Infections

Interventions

DRUG: Anti-D

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)